Author: Clairity, Inc.

Posted Date:

April 14, 2026

Clairity Announces Update to NCCN Guidelines to Include AI Mammogram-Based Risk Tool to Identify Future Breast Cancer Risk in Women Missed by Traditional Methods

Clairity, Inc.

April 14, 2026
First Patient Receives FDA-Authorized Clairity Breast Score, Marking a New Era in AI Empowered Breast Cancer Risk Assessment

Clairity, Inc.

February 23, 2026
Clairity Founder and CEO, Dr. Connie Lehman, Named to TIME’s 2026 TIME100 Health List

Clairity, Inc.

February 12, 2026